Is it reasonable for "digoxin tablets" to soar ten times after the government's price cancellation?

Source: China Economic Net / Lin huocan 2015-06-08 low price drugs cancel the maximum retail price limit set by the government, in order to ensure that these low-cost drugs and commonly used drugs can be bought and used by ordinary people The relevant departments should pay more attention to confirm whether there is any illegal behavior behind the price rise, such as manufacturers or distributors operating the price by using the market monopoly position Recently, media reported that the price of digoxin tablet has increased 10 times since June 1, when the government cancelled the pricing of most drugs Is the price of digoxin "skyrocketing" caused by drug price reform? "Let alone from the time node of price adjustment, the price adjustment of digoxin tablets took place before May this year, rather than after the formal implementation of the drug price reform program on June 1 this year It is not objective to simply attribute the rise of digoxin tablet price to the reform of drug price Chang Feng, director of the Institute of pharmaceutical price of China Pharmaceutical University, told the economic daily Digoxin tablet is mainly used to treat congenital heart disease and chronic cardiac insufficiency Changfeng said that for a long time, due to the low price of digoxin tablets, enterprises are reluctant to produce, and drug supply is often in short supply In April 2014, in order to solve the problem of the disappearance of some low-cost drugs, the national development and Reform Commission issued a notice to cancel the maximum retail price limit set by the government for low-cost drugs, implement the upper limit standard control of daily average expenses (3 yuan for chemical drugs and 5 yuan for Chinese patent drugs), and drug manufacturers and operators formulate specific purchase and sale prices according to the drug production cost and market supply and demand The purpose of this reform is to ensure that these cheap drugs and commonly used drugs can be bought and used by ordinary people "In the case of serious cost inversion, if the price is not adjusted, the production enterprises are likely to stop production from the perspective of cost-benefit, which will cause the shortage of market supply, even the disappearance of low-cost drugs, and the people will be greatly affected." Chang Feng said It is understood that there are 11 registered manufacturers of digoxin tablets, but at present there are only two manufacturers in the market, and all APIs are imported Since the second half of 2014, the raw material import price of digoxin tablets has increased rapidly, from 75000 yuan per kilogram to 400000 yuan The market price of the drug gradually increased Changfeng said that the price of a bottle of digoxin rose from 6.8 yuan to 68 yuan It seems that the price has increased 10 times, which is frightening However, according to the information reported by the media, a bottle of digoxin tablet is 100 tablets, half of which can be taken for 200 days every day Based on the rising price, the daily average cost of the patients is about 0.34 yuan On May 5 this year, the national development and Reform Commission, etc The "opinions on promoting drug price reform" issued by the Department clearly cancels the government pricing of most drugs, and the actual transaction price of drugs is mainly formed by market competition; meanwhile, the notice on strengthening the supervision of drug market price behavior is issued simultaneously, which puts forward relevant measures to strengthen the supervision and carry out special inspection, and explicitly requires that after the cancellation of the government pricing of drugs, drug producers The independent pricing of producers and operators shall be in accordance with laws and regulations, follow the principles of fairness, legality and good faith, reasonably set prices, and consciously maintain the market price order "In view of the obvious increase in the price of digoxin tablets, the relevant departments should pay more attention to and investigate, especially to confirm whether there is any illegal behavior behind the price increase, such as the manufacturer or dealer using the market monopoly position to operate the price." Chang Feng said The reporter learned that the price rise of digoxin tablets has attracted the attention of the competent price department The relevant departments are investigating the production and operation of digoxin tablets If the relevant producers and operators bid up the prices and abuse the dominant position of the market to disturb the price order of the drug market, they will be severely punished (original title: is it reasonable for the price of digoxin tablets to skyrocket 10 times after the government's cancellation of drug pricing?)